Skip to main content
. 2022 Mar 4;12(6):2845–2858. doi: 10.1016/j.apsb.2022.02.031

Table 1.

The selectivity of YPD-29B on different immune checkpoints.

Immune checkpoint IC50 (nmol/L)
YPD-29B Positive control
hPD-1/hPD-L1 0.32 2.2 (PD-1 antibody)
hB7-1/hPD-L1 0.3 2.5 (PD-L1 antibody)
mPD-1/mPD-L1 >10,000 2.7 (mPD-L1 antibody)
hPD-1/hPD-L2 >10,000 2.2 (PD-1 antibody)
hCD28/hB7-1 >10,000 7.8 (CTLA4 Fc)
hCD28/hB7-2 >10,000 13 (CTLA4 Fc)
hCTLA4/hB7-1 >10,000 2.8 (CTLA4 antibody)
hCTLA4/hB7-2 >10,000 5.3 (CTLA4 antibody)
LAG3/MHC IIa >10,000 30 (LAG3 antibody)
a

HTRF.